Trial intelligence / Profile preview

REDUNING injection versus oseltamivir for influenza high fever

ChiCTR-TRC-13004045Phase 2Completed

Sponsor
Tianjin University of Traditional Chinese Medicine
Start
Jan 2013
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Reduning in influenza (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoint: Time of temperature to normal. Started Jan 2013; status: completed.

02

Drugs

Reduning
03

Conditions

influenza

Beyond the preview

Go deeper on ChiCTR-TRC-13004045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13004045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call